Indivior Pharmaceuticals (INDV) Total Current Liabilities (2021 - 2026)
Indivior Pharmaceuticals (INDV) reported Total Current Liabilities of $868 million for Q2 2026, down 17.8% from $1.06 billion a year earlier but up 11.4% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Total Current Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2025, Indivior Pharmaceuticals posted Total Current Liabilities of $914 million, down 1.1% from FY2024.
- Total Current Liabilities has a four-year compound annual growth rate of 3.3% (FY2021 to FY2025).
- By year, Total Current Liabilities came in at $924 million in FY2024 (-27.9%), $1.28 billion in FY2023 (+25.7%), $1.02 billion in FY2022 (+26.7%) and $804 million in FY2021.
- Five-year quarterly Total Current Liabilities spans a low of $779 million in Q1 2026 and a high of $1.28 billion in Q4 2023.
- Year over year, Total Current Liabilities has now declined in each of the last three quarters, with an average decline of 17.3% over the last four quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $779 million (Q1 2026), $914 million (Q4 2025) and $965 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | Indivior Pharmaceuticals | 4.35 Bn | 3.32 Bn | 294.00 Mn | 868.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 868.00 Mn |
| Mar 31, 2026 | 779.00 Mn |
| Dec 31, 2025 | 914.00 Mn |
| Sep 30, 2025 | 965.00 Mn |
| Jun 30, 2025 | 1.06 Bn |
| Mar 31, 2025 | 1.01 Bn |
| Dec 31, 2024 | 924.00 Mn |
| Dec 31, 2023 | 1.28 Bn |
| Dec 31, 2022 | 1.02 Bn |
| Dec 31, 2021 | 804.00 Mn |
API Access
Indivior Pharmaceuticals Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();